Objective: To analyse changes in muscle strength, physical performance and quality of life during intravenous immunoglobulin (IVIg) treatment in patients with post-polio syndrome.
Design: Open clinical trial.
Patients: A total of 14 patients (6 women, 8 men; mean age 57 years, range 43–67 years) were included in the study.
Intervention: Treatment with 90 g IVIg (30 g dai ...
Pages: 138-140